《晚期前列腺癌：从实验室到临床》特刊社论
Editorial for the Special Edition of Advanced Prostate Cancer: From Bench to Bedside.
作者信息
Saad Fred
机构信息
Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, QC H2X 3E4, Canada.
出版信息
Cancers (Basel). 2023 Feb 16;15(4):1247. doi: 10.3390/cancers15041247.
Abstract
Prostate cancer is generally viewed as a slow-growing unaggressive cancer, yet it is one of the most commonly diagnosed cancers and a leading cause of morbidity and mortality in men around the world [...].
摘要
前列腺癌通常被视为一种生长缓慢、侵袭性较弱的癌症，但它却是最常被诊断出的癌症之一，也是全球男性发病和死亡的主要原因之一[...]。
相似文献
1
Editorial for the Special Edition of Advanced Prostate Cancer: From Bench to Bedside.《晚期前列腺癌：从实验室到临床》特刊社论
Cancers (Basel). 2023 Feb 16;15(4):1247. doi: 10.3390/cancers15041247.
3
Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.2034 年韩国男性主要癌症的发病率和死亡率预测，重点关注前列腺癌。
Investig Clin Urol. 2022 Mar;63(2):175-183. doi: 10.4111/icu.20210405.
4
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.经计算的快速增长型良性前列腺增生——一种发生临床前列腺癌的风险因素。
Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827.
5
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.前列腺癌干预与观察试验（ProtecT）中被排除的晚期前列腺癌男性患者的死亡率
Eur Urol. 2017 Mar;71(3):381-388. doi: 10.1016/j.eururo.2016.09.040. Epub 2016 Oct 6.
6
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden.2000 年至 2016 年期间瑞典全国范围内基于人群的研究：局部晚期前列腺癌男性患者的治疗和死亡率变化。
BJU Int. 2020 Jul;126(1):142-151. doi: 10.1111/bju.15077. Epub 2020 May 8.
7
Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines.前列腺癌：生物学、发病率、检测方法、治疗方法和疫苗。
Curr Top Med Chem. 2020;20(10):847-854. doi: 10.2174/1568026620666200224100730.
8
Awareness of prostate cancer and its associated factors among men 40 years of age and older in Mizan Aman town, Bench Sheko zone, Southern Nations, Nationalities, and Peoples' Region, South West Ethiopia, 2019.2019年埃塞俄比亚西南部民族、国籍和人民地区本奇谢科州米赞阿曼镇40岁及以上男性对前列腺癌及其相关因素的认知情况
Front Oncol. 2022 Oct 24;12:976810. doi: 10.3389/fonc.2022.976810. eCollection 2022.
9
Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer.局部和晚期临床检测前列腺癌患者血清胰岛素样生长因子与死亡率的关系。
Cancer Causes Control. 2012 Feb;23(2):347-54. doi: 10.1007/s10552-011-9883-8. Epub 2011 Dec 20.
10
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.晚期前列腺癌治疗中早期与延迟雄激素抑制疗法的比较
Cochrane Database Syst Rev. 2002(1):CD003506. doi: 10.1002/14651858.CD003506.
本文引用的文献
1
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.在雄激素非依赖性紫杉烷敏感和紫杉烷耐药的人前列腺癌细胞中共同靶向表皮生长因子受体（ErbB）和磷脂酰肌醇-3激酶/蛋白激酶B（PI3K/AKT）轴
Cancers (Basel). 2022 Sep 23;14(19):4626. doi: 10.3390/cancers14194626.
2
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?转移性去势抵抗性前列腺癌的靶向治疗方法：哪些数据？
Cancers (Basel). 2022 Aug 29;14(17):4189. doi: 10.3390/cancers14174189.
3
Where Do We Stand in the Management of Oligometastatic Prostate Cancer? A Comprehensive Review.在寡转移前列腺癌的管理方面我们处于什么位置？一项全面综述。
Cancers (Basel). 2022 Apr 16;14(8):2017. doi: 10.3390/cancers14082017.
4
High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality.良性肿瘤周围前列腺腺体中高角蛋白-7表达可预测骨转移的发生及前列腺癌特异性死亡率。
Cancers (Basel). 2022 Mar 23;14(7):1623. doi: 10.3390/cancers14071623.
5
Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers.高危基因突变携带者前列腺癌的临床管理
Cancers (Basel). 2022 Feb 16;14(4):1004. doi: 10.3390/cancers14041004.
6
Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer-Where Are We Now?雄激素受体与聚（ADP-核糖）聚合酶的联合抑制作为前列腺癌的一种新型治疗模式——我们目前的进展如何？
Cancers (Basel). 2022 Feb 4;14(3):801. doi: 10.3390/cancers14030801.
7
Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer.亚洲转移性前列腺癌患者管理中的种族药物基因组学差异
Cancers (Basel). 2022 Jan 14;14(2):407. doi: 10.3390/cancers14020407.
8
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer.靶向内在凋亡途径：前列腺癌的一个机会窗口。
Cancers (Basel). 2021 Dec 23;14(1):51. doi: 10.3390/cancers14010051.
9
Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer.通过液体活检对同源重组修复基因突变进行特征分析：奥拉帕利和阿比特龙治疗转移性去势抵抗性前列腺癌的II期试验
Cancers (Basel). 2021 Nov 20;13(22):5830. doi: 10.3390/cancers13225830.
10
A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer.高危前列腺癌当前治疗模式综述
Cancers (Basel). 2021 Aug 24;13(17):4257. doi: 10.3390/cancers13174257.
Zotero 插件